Markus Schwerzmann is a clinician scientist at the University Hospital Inselspital in Bern, Switzerland. He trained in Internal Medicine and Cardiology in Switzerland, followed by a fellowship in adult congenital heart disease at the Toronto Congenital Cardiac Centre for Adults (UHN/Toronto General Hospital). He is currently directing the Adult Congenital Heart Disease Unit at the Center for Congenital Heart Disease in Bern. The center was founded in 2012 with the vision to offer comprehensive continuous care to all patients with congenital heart disease, independent of their age.
His research interests focus on clinical outcomes in adult congenital heart disease, particularly on the failing right ventricle. He is the principal investigator of an international placebo-controlled randomized clinical trial aiming to improve the fate of patients with a systemic right ventricle. Additional research interests include the transition process and patient education as well as care perspectives when approaching end of life.
He is currently an ex-officio board member of the European Society of Cardiology (ESC) working group for Grown-Up Congenital Heart Disease and of the Council on Stroke of the ESC. He (co)- authored > 70 peer reviewed papers and served as reviewer for different ESC guidelines.